Optimize Biotherapeutics Design with In Silico Techniques

Biotherapeutics are dominated by antibodies and antibody-like entities that allow therapeutics to target individual cells with unprecedented precision. Learn how in silico techniques can greatly assist in the understanding of protein-target interactions and identifying formulation issues early in the drug discovery process to improve outcomes.

Register free: https://www.pharmtech.com/pt/silico-techniques

Event Overview:

Biotherapeutics have firmly established their significance in the pharmaceutical R&D scene over the past two decades. They are dominated by antibodies and antibody-like entities that allow therapeutics to target individual cells with unprecedented precision. Despite their therapeutic advantages, developing and optimizing these modalities remains a significant challenge.

In silico techniques can greatly assist in the understanding of protein-target interactions and identifying potential formulation issues early in the R&D process to improve outcomes. Learn how to improve your competitiveness and shorten your timelines by focusing your expensive physical experimentation on projects with a greater likelihood to succeed.

Key Learning Objectives

• How candidate leads are modeled to understand protein-target interactions, and improve binding affinity, selectivity and efficacy.
• How biophysical properties are predicted to provide greater insight and support of design decisions.
• How BIOVIA Discovery Studio Simulation can help advance smarter biotherapeutics design.

Who Should Attend

• Biotech, Pharma & CRO companies
• Head / VP / Director of R&D
• Head / VP / Director of Drug Discovery
• Computational Chemists
• Medicinal Chemists
• Molecular Modelers
• Data Scientists
• Principle Scientists
• Drug Hunters

Speaker

Tien Luu
Product Manager and Principal Scientific Specialist
BIOVIA Dassault Systèmes

Tien Luu is the Product Manager and Principal Scientific Specialist at BIOVIA Dassault Systèmes, managing aspects of life science modeling and simulation predictive science solutions. She began her career as a Scientific Specialist after receiving her Ph.D. in Chemistry from the University of Wollongong, Australia. In her 20+ year career at BIOVIA, Tien has been steadfast in her passion and excitement for helping customers accelerate R&D and improving customer experiences and product successes. In addition, she continues to be an active leader in scientific software product development, new program initiatives, and new fundamental and applied scientific research.

Register free: https://www.pharmtech.com/pt/silico-techniques